Both in Biotechnology
CRISPR Therapeutics AG vs Relay Therapeutics
Over the past year CRSP returned −19.6% and RLAY returned +157.0%; their daily moves had a correlation of 0.32.
CRSP −19.6% RLAY +157.0%Growth of $1, one year, split-adjusted
| Metric | CRSP | RLAY |
|---|---|---|
| Price | $51.42 | $18.35 |
| Market cap | $4.97B | $4.02B |
| Today | −5.23% | −5.75% |
| 1 month | −7.3% | −0.8% |
| 6 months | −0.4% | +44.3% |
| Year to date | −1.9% | +116.9% |
| 1 year | −17.8% | +151.0% |
| Revenue growth (YoY) | +1041.4% | −48.3% |
| Gross margin | 100.0% | 100.0% |
| Net margin | −895.3% | −23916.3% |
| P/E (TTM) | — | — |
| Price / sales | 371.3× | 388.5× |
| Net cash | $1.78B | $910.9M |
| Dividend yield | — | — |
| Volatility (60d) | 53.4% | 47.2% |
| Short % of float | 21.0% | 27.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).